Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Bibliographische Detailangaben
Hauptverfasser:	Lowenberg, E, Cohen, S, van den Born, B, Meijers, J, Levi, M, Dondorp, A
Format:	Conference item
Veröffentlicht:	2008

Ähnliche Einträge

Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
von: Löwenberg, E, et al.
Veröffentlicht: (2010)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
von: Birnie, E, et al.
Veröffentlicht: (2017)

The von Willebrand factor – ADAMTS‐13 axis in malaria
von: Andrew S. O’Donnell, et al.
Veröffentlicht: (2022-01-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
von: Stefano Lancellotti, et al.
Veröffentlicht: (2013-09-01)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
von: Emma Birnie, et al.
Veröffentlicht: (2017-03-01)

Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.
von: Zuben E Sauna, et al.
Veröffentlicht: (2009-08-01)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory
von: J-D Studt, et al.
Veröffentlicht: (2003-06-01)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
von: Emma Birnie, et al.
Veröffentlicht: (2020-09-01)

Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13
von: Shobhit Gogia, et al.
Veröffentlicht: (2017-10-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES-rev1-MJHID-2013
von: Raimondo De Cristofaro
Veröffentlicht: (2014-08-01)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
von: Gurbey Ocak, et al.
Veröffentlicht: (2021-06-01)

Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor
von: Clemens L. Bockmeyer, et al.
Veröffentlicht: (2008-01-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
von: Benjamin Reardon, et al.
Veröffentlicht: (2021-09-01)

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
von: Deirdre Larkin, et al.
Veröffentlicht: (2009-03-01)

Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond: A Question of Balance
von: Emmanuel J Favaloro, et al.
Veröffentlicht: (2021-07-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
von: E. V. Slukhanchuk, et al.
Veröffentlicht: (2023-01-01)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
von: Taleen A MacArthur, et al.
Veröffentlicht: (2021-12-01)

An association between the L1565 variant of von Willebrand factor and susceptibility to proteolysis by ADAMTS13
von: James Anthony Davies, et al.
Veröffentlicht: (2007-02-01)

Histone-induced thrombotic thrombocytopenic purpura in adamts13−/− zebrafish depends on von Willebrand factor
von: Liang Zheng, et al.
Veröffentlicht: (2020-04-01)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
von: Abdulla Ahmed, et al.
Veröffentlicht: (2021-10-01)

The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
von: Stefano Lancellotti, et al.
Veröffentlicht: (2022-04-01)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
von: Kanwal Singh, et al.
Veröffentlicht: (2021-01-01)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
von: Waldemar E. Wysokinski, MD, PhD, et al.
Veröffentlicht: (2021-03-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
von: R.P.S. Soares, et al.
Veröffentlicht: (2013-04-01)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
von: Dalia A. Bashir MD, et al.
Veröffentlicht: (2021-02-01)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
von: Junxian Yang, et al.
Veröffentlicht: (2020-12-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
von: R.P.S. Soares, et al.
Veröffentlicht: (2013-05-01)

Comparative assessment of changes ADAMTS-13/von Willebrand factor axis in singleton and bichorial biamniotic pregnancy
von: F. Е. Yagubova, et al.
Veröffentlicht: (2024-09-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
von: K. N. Grigoreva, et al.
Veröffentlicht: (2021-03-01)

Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis
von: Elvira Grandone, et al.
Veröffentlicht: (2022-02-01)

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
von: N. R. Gashimova, et al.
Veröffentlicht: (2023-03-01)

Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome
von: Yoko Yoshida, et al.
Veröffentlicht: (2017-09-01)

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
von: Hanna L. Obermeier, et al.
Veröffentlicht: (2019-07-01)

The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
von: Giovanni Tiscia, et al.
Veröffentlicht: (2021-09-01)

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy
von: Shinya Yamada, et al.
Veröffentlicht: (2024-07-01)

Imbalance of the von Willebrand Factor — ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
von: Max Braune, et al.
Veröffentlicht: (2024-06-01)

Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activity
von: Marie Scully
Veröffentlicht: (2020-11-01)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
von: Julien Demagny, et al.
Veröffentlicht: (2021-01-01)

Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery
von: Katja Susanne Häußler MD, et al.
Veröffentlicht: (2020-10-01)

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
von: Caroline Pereira Domingueti, et al.
Veröffentlicht: (2015-01-01)